# Gland Pharma Limited – FDA Inspection, Mar 31, 2017

Source: https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/f11bc613-6f2c-4144-ad0f-51acc97a860d
Source feed: FDA_Inspections

> FDA inspection 1010051 of Gland Pharma Limited, March 31, 2017. Classification: No Action Indicated (NAI). Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1010051
- Company Name: Gland Pharma Limited
- Inspection Date: 2017-03-31
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1220251 - 2023-07-28
- [FDA Inspection 1110628 - 2019-11-01](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/dcb210ce-c362-4c32-9e94-f2665152f61b)
- FDA Inspection 1061075 - 2018-06-15
- FDA Inspection 1056489 - 2018-05-18
- FDA Inspection 936901 - 2015-06-30

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/samantha-j-bradley/ba45f64f-07a9-4933-833f-b9b339c57783)

Company: https://www.keypedia.com/companies/gland-pharma-limited/9d02bb1e-32f9-45c5-9b90-f52622553c63

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
